Spyre Therapeutics, Inc.
SYRE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$208 | -$339 | -$84 | -$66 |
| Dep. & Amort. | $0 | $1 | $2 | $2 |
| Deferred Tax | $0 | $0 | -$0 | $0 |
| Stock-Based Comp. | $45 | $26 | $7 | $8 |
| Change in WC | -$5 | -$5 | -$6 | $2 |
| Other Non-Cash | $10 | $218 | $1 | $1 |
| Operating Cash Flow | -$157 | -$100 | -$80 | -$54 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$0 | -$1 |
| Net Acquisitions | $0 | $3 | $0 | $0 |
| Inv. Purchases | -$599 | -$167 | -$40 | -$133 |
| Inv. Sales/Matur. | $246 | $40 | $97 | $111 |
| Other Inv. Act. | $0 | $15 | $0 | $0 |
| Investing Cash Flow | -$353 | -$108 | $57 | -$23 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$0 | -$0 | -$1 |
| Stock Issued | $236 | $169 | $43 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $175 | $192 | $0 | $2 |
| Financing Cash Flow | $411 | $361 | $43 | $1 |
| Forex Effect | -$0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | -$100 | $153 | $19 | -$75 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $189 | $36 | $17 | $92 |
| End Cash | $89 | $189 | $36 | $17 |
| Free Cash Flow | -$157 | -$100 | -$80 | -$54 |